Last Published 07.01.2026 Effective Date: 07.01.2026 This policy addresses the use of Adzynma (ADAMTS13, recombinant-krhn) for the treatment of congenital thrombotic thrombocytopenic purpura (cTTP)
Lu Y, Li L, Lin Z et al
We guarantee a purity level exceeding 99%, which is verified through High-Performance Liquid Chromatography (HPLC)
Red blood cells carry oxygen in the blood, so anemia can cause symptoms such as fatigue or shortness of breath
Liposomal glutathione is a form of glutathione encapsulated in liposomes, which are tiny spherical vesicles made of phospholipids
Secondary outcomes The secondary outcomes are as follows: type 2 diabetes, glucose, HbA1c, insulin, lipid profile (LDL-cholesterol, HDL-cholesterol, triglycerides and apolipoprotein B), systolic blood pressure, diastolic blood pressure, and body mass index (BMI), which are well-established risk factors for CVD in clinical practice, or recently identified to be related to CVD in MR, such as apolipoprotein B [30, 31]
